Teriflunomide

Sold as Aubagio, Auberif, Teriflunomide teva, Aubamide, Teritemso, Teriflunomide adco, Teriflunomide ascend, Reltif, Denomide, Flunovo, Bagiocord, * tirifoma, Teriflunomide hetero, Teriflunomide PD, Scleromide

S4Read from the PI-PIL document and verified

C₁₂H₉F₃N₂O₂270.21 g/mol

(Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide

Drag to rotate. Structure from PubChem CID 54684141.

Loading Wikipedia summary

Registration

Applicants: 11
Registrations: 15
Schedule source: SAHPRA documentation

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Sanofi-aventis South Africa (Pty) Ltd	Aubagio	14 mg	470859	S4	PI PIL
Sanofi Industries South Africa (Pty) LtdCertificate held by Sanofi-aventis South Africa (Pty) Ltd	Auberif	14 mg	470860	S4	PI PIL
Teva Pharmaceuticals (Pty) Ltd	Teriflunomide teva	14 mg	540737	S4	PI PIL
Cipla Medpro (Pty) Ltd	Aubamide	14 mg	550228	S4	PI PIL
Adcock ingram limited	Teritemso, Teriflunomide adco	14 mg	550244, 550245.244	S4	PI PIL
Ascend Laboratories (Pty) Ltd	Teriflunomide ascend	14 mg	550633	S4	None
Lebasi Pharmaceuticals (Pty) Ltd	Reltif, Denomide, Flunovo	Not stated	550838, 550839.838, 550840.838	S4	None
Accord Healthcare (Pty) Ltd	Bagiocord	Not stated	560307	S4	None
Hetero Drugs South Africa (Pty) Ltd	* tirifoma, Teriflunomide hetero	Not stated	560538, 560539	S4	None
Pharma Dynamics (Pty) Ltd	Teriflunomide PD	Not stated	561234	S4	None
Gen-eye (Pty) Ltd	Scleromide	Not stated	570534	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Aubagio EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	14 mgFilm-coated tablets	47085947/32.16/0859Approved 20 April 2023	Registered	S4	PI PIL
Auberif EACH FILM-COATED TABLET CONTAINS: TERIFLUNOMIDE 14,0 mg	14 mgFilm-coated tablets	47086047/32.16/0860Approved 26 October 2023	Registered	S4	PI PIL
Teriflunomide 14 teva	14 mgFilm-coated tablets	54073754/32.16/0737Approved 7 February 2025	Registered	S4	PI PIL
Aubamide 14 MG	14 mgTablet	55022855/32.16/0228Approved 28 June 2022	Registered	S4	PI PIL
Teritemso EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	14 mgTablet	55024455/32.16/0244Approved 13 June 2023	Registered	S4	PI PIL
Teriflunomide adco EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	14 mgTablet	550245.24455/32.16/0245.244Approved 13 June 2023	Registered	S4	PI PIL
Teriflunomide 14 MG ascend EACH TABLET CONTAINS TERIFLUNOMIDE 10,0 mg	14 mg	55063355/32.16/0633	Registered	S4	None
Reltif EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	Not listed	55083855/32.16/0838	Registered	S4	None
Denomide EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	Not listed	550839.83855/32.16/0839.838	Registered	S4	None
Flunovo EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	Not listed	550840.83855/32.16/0840.838	Registered	S4	None
Bagiocord EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	Not listed	56030756/32.16/0307	Registered	S4	None
* tirifoma EACH TABLET CONTAINS: TERIFLUNOMIDE 14,0 mg	Not listed	56053856/32.16/0538	Registered	S4	None
Teriflunomide hetero EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	Not listed	56053956/32.16/0539.538	Registered	S4	None
Teriflunomide PD EACH TABLET CONTAINS TERIFLUNOMIDE 14,0 mg	Not listed	56123456/32.16/1243	Registered	S4	None
Scleromide EACH TABLET CONTAINS: TERIFLUNOMIDE 14,0 mg	Not listed	57053457/32.16/0534	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Teriflunomide

S4: Teriflunomide
Consolidated Schedules 06 July 2026, line 8138

Pharmacological class: Others. (class 32.16)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Aubagio, Sanofi-aventis South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsAubagio, Sanofi-aventis South Africa (Pty) Ltd Patient information leaflet (PIL)For patients and carersAubagio, Sanofi-aventis South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background